Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)
Nkarta Is Maintained at Outperform by Mizuho
Nkarta Analyst Ratings
A Quick Look at Today's Ratings for Nkarta(NKTX.US), With a Forecast Between $11 to $18
Needham Maintains Nkarta(NKTX.US) With Buy Rating, Cuts Target Price to $11
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Veeva Systems (VEEV)
Nkarta Is Maintained at Buy by Needham
Nkarta Analyst Ratings
William Blair Maintains Nkarta(NKTX.US) With Buy Rating
TD Cowen Maintains Nkarta(NKTX.US) With Buy Rating
TD Cowen Sticks to Its Buy Rating for Nkarta (NKTX)
Rodman & Renshaw Initiates Nkarta(NKTX.US) With Buy Rating, Announces Target Price $14
Mizuho Securities Maintains Nkarta(NKTX.US) With Buy Rating, Cuts Target Price to $20
A Quick Look at Today's Ratings for Nkarta(NKTX.US), With a Forecast Between $13 to $22
HC Wainwright & Co. Maintains Buy on Nkarta, Lowers Price Target to $22
A Quick Look at Today's Ratings for Nkarta(NKTX.US), With a Forecast Between $13 to $22
Nkarta Price Target Maintained With a $13.00/Share by Needham
Nkarta Analyst Ratings
Raymond James Upgrades Nkarta to Strong Buy, Maintains Price Target to $16
TD Cowen Remains a Buy on Nkarta (NKTX)